Business Description
![Pharma Mar SA Pharma Mar SA logo](https://static.gurufocus.com/logos/0C00000WTW.png?14)
Pharma Mar SA
ISIN : ES0169501022
Compare
Compare
Traded in other countries / regions
PHM.SpainPHMMF.USA0RC6.UKPMRA.GermanyPHM.AustriaPHM1.Mexico IPO Date
2015-11-03Description
Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and market insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology, Diagnostics, Consumer chemicals, and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.97 | |||||
Equity-to-Asset | 0.58 | |||||
Debt-to-Equity | 0.21 | |||||
Debt-to-EBITDA | 13.41 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 4.22 | |||||
Beneish M-Score | -2.39 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -15.7 | |||||
3-Year EBITDA Growth Rate | -69 | |||||
3-Year EPS without NRI Growth Rate | -82.5 | |||||
3-Year Book Growth Rate | 24.6 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
9-Day RSI | 100 | |||||
14-Day RSI | 100 | |||||
6-1 Month Momentum % | 30.01 | |||||
12-1 Month Momentum % | 30.01 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.62 | |||||
Quick Ratio | 2.14 | |||||
Cash Ratio | 1.73 | |||||
Days Inventory | 1466.76 | |||||
Days Sales Outstanding | 60.65 | |||||
Days Payable | 1020.52 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Dividend Growth Rate | 10.6 | |||||
3-Year Average Share Buyback Ratio | 0.9 | |||||
Shareholder Yield % | 4.37 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 94.3 | |||||
Operating Margin % | -3.56 | |||||
Net Margin % | 1.25 | |||||
FCF Margin % | -21.45 | |||||
ROE % | 0.99 | |||||
ROA % | 0.58 | |||||
ROIC % | 2.32 | |||||
ROC (Joel Greenblatt) % | -5.81 | |||||
ROCE % | -1.13 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 324.26 | |||||
PE Ratio without NRI | 407.21 | |||||
Shiller PE Ratio | 25.99 | |||||
PS Ratio | 3.83 | |||||
PB Ratio | 3.18 | |||||
Price-to-Tangible-Book | 3.21 | |||||
EV-to-EBIT | -158.45 | |||||
EV-to-EBITDA | 156.5 | |||||
EV-to-Revenue | 2.9 | |||||
EV-to-FCF | -14.17 | |||||
Price-to-Projected-FCF | 0.97 | |||||
Price-to-Median-PS-Value | 0.9 | |||||
Price-to-Graham-Number | 7.62 | |||||
Price-to-Net-Current-Asset-Value | 6.12 | |||||
Price-to-Net-Cash | 32.98 | |||||
Earnings Yield (Greenblatt) % | -0.63 | |||||
FCF Yield % | -5.9 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pharma Mar SA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 162.14 | ||
EPS (TTM) (€) | 0.108 | ||
Beta | 0.35 | ||
Volatility % | 33.48 | ||
14-Day RSI | 100 | ||
14-Day ATR (€) | 0.00013 | ||
20-Day SMA (€) | 42.54 | ||
12-1 Month Momentum % | 30.01 | ||
52-Week Range (€) | 32.72 - 42.54 | ||
Shares Outstanding (Mil) | 17.48 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Pharma Mar SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Pharma Mar SA Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Pharma Mar SA Frequently Asked Questions
What is Pharma Mar SA(CHIX:PHMe)'s stock price today?
The current price of CHIX:PHMe is €42.54. The 52 week high of CHIX:PHMe is €42.54 and 52 week low is €32.72.
When is next earnings date of Pharma Mar SA(CHIX:PHMe)?
The next earnings date of Pharma Mar SA(CHIX:PHMe) is 2024-07-26 Est..
Does Pharma Mar SA(CHIX:PHMe) pay dividends? If so, how much?
Pharma Mar SA(CHIX:PHMe) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |